128 related articles for article (PubMed ID: 7166918)
1. [Immunological detection of an antigen associated with human bladder carcinoma cell lines].
Tsukahara K
Nihon Hinyokika Gakkai Zasshi; 1982 Oct; 73(10):1249-58. PubMed ID: 7166918
[No Abstract] [Full Text] [Related]
2. Detection of antigenic differences and similarities between human transitional cell carcinoma cell lines using rabbit antisera.
Bloom ET; Brown DE
Urol Res; 1980; 8(1):5-13. PubMed ID: 6154368
[No Abstract] [Full Text] [Related]
3. Immunological characterization of cell lines establishing from malignant and normal human urothelium.
Vilien M; Wolf H; Rasmussen F
Eur J Cancer (1965); 1981 Mar; 17(3):321-7. PubMed ID: 7262169
[No Abstract] [Full Text] [Related]
4. The detection of transitional cell bladder cancer antigen on established cell lines.
Boxer RJ; Sofen H; Saxon A
Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
[No Abstract] [Full Text] [Related]
5. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
Pizza G; Viza D; Fini M; Cuzzocrea D; Menniti D; Corrado F
Eur Urol; 1980; 6(1):45-7. PubMed ID: 7353578
[TBL] [Abstract][Full Text] [Related]
6. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
Bloom ET
Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
[TBL] [Abstract][Full Text] [Related]
7. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum.
Bloom ET
Urol Res; 1977; 5(3):141-8. PubMed ID: 919114
[TBL] [Abstract][Full Text] [Related]
8. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
Gelabert Mas A; Corominas J; Arango O
Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
[No Abstract] [Full Text] [Related]
9. [Prognostic evaluation of patients with cancer of the bladder by detection of ABH surface antigens].
Srougi M; Alves VA; Gayotto LC; Raia S; Arap S
AMB Rev Assoc Med Bras; 1987; 33(3-4):67-70. PubMed ID: 3501142
[No Abstract] [Full Text] [Related]
10. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
BubenÃk J
Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
Schneider MU; Paulie S; Troye M; Perlmann P
Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
[TBL] [Abstract][Full Text] [Related]
12. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
[TBL] [Abstract][Full Text] [Related]
14. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
Hoshi S; Orikasa S; Numata I; Nose M
J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
[TBL] [Abstract][Full Text] [Related]
15. [The study of mouse monoclonal antibody to human transitional cell carcinoma of the bladder].
Takahashi S; Takahashi N; Takahashi K; Koizumi Y; Kawaguchi T; Togashi S; Suzuki T; Funyu T
Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):791-801. PubMed ID: 3694976
[No Abstract] [Full Text] [Related]
16. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
17. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
Schneider MU; Troye M; Paulie S; Perlmann P
Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines.
Sasaki M
Keio J Med; 1984 Apr; 33(1):39-56. PubMed ID: 6384610
[No Abstract] [Full Text] [Related]
19. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
[TBL] [Abstract][Full Text] [Related]
20. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines.
Paulie S; Hansson Y; Lundblad ML; Perlmann P
Int J Cancer; 1983 Mar; 31(3):297-303. PubMed ID: 6826254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]